Clinical Trials Browser

Completed × Ovarian Neoplasms × regorafenib × Clear all

NCT02584465 2023-09-06

REGOVAR

Phase 2 Completed

Ovarian Neoplasms

NCT02307500 2022-09-10

RESOUND

Phase 2 Completed

DermatologicGastrointestinalGynecologicSarcomaThoracic

Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Thymoma

NCT02736305 2022-06-13

Use of Regorafenib in Recurrent Epithelial Ovarian Cancer

Phase 2 Completed

Ovarian Neoplasms